menu search

FBT / FBT: No Great Prospects Despite Huge Price Gain Over Past One Year

FBT: No Great Prospects Despite Huge Price Gain Over Past One Year
Most stocks in FBT's biotechnology portfolio beat returns of S&P 500 during the past one year. FBT also registered a price growth of 15.5 percent. However, over the past five months, return has been much lower than S&P 500, and price growth of FBT's portfolio has largely been disappointing. There is a likelihood of this price falling further down to cross the 52-week low. This assumption gets further validation through moving average indicators. Read More
Posted: May 31 2023, 05:18
Author Name: Seeking Alpha
Views: 101981

FBT News  

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

By Zacks Investment Research
September 27, 2023

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Launched on 06/19/2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund offering broad exposure to the Health C more_horizontal

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

By Zacks Investment Research
September 26, 2023

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a pa more_horizontal

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

By Zacks Investment Research
July 26, 2023

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotec more_horizontal

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

By Zacks Investment Research
July 24, 2023

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure more_horizontal

FBT: No Great Prospects Despite Huge Price Gain Over Past One Year

By Seeking Alpha
May 31, 2023

FBT: No Great Prospects Despite Huge Price Gain Over Past One Year

Most stocks in FBT's biotechnology portfolio beat returns of S&P 500 during the past one year. FBT also registered a price growth of 15.5 percent. How more_horizontal

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

By Zacks Investment Research
May 26, 2023

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Launched on 06/19/2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad expo more_horizontal

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

By Zacks Investment Research
May 19, 2023

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure more_horizontal

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

By Zacks Investment Research
March 16, 2023


Search within

Pages Search Results: